Yarong Hao

756 total citations
26 papers, 604 citations indexed

About

Yarong Hao is a scholar working on Molecular Biology, Epidemiology and Rheumatology. According to data from OpenAlex, Yarong Hao has authored 26 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in Yarong Hao's work include Liver Disease Diagnosis and Treatment (5 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yarong Hao is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yarong Hao collaborates with scholars based in China, United Kingdom and United States. Yarong Hao's co-authors include Xiongfeng Xu, Yi Peng, Jian Qin, Kai Xu, Jianbo Lǚ, Jinmei Yang, Fang Cheng, Xue Zhang, Xiang Zhang and Tao Luo and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Yarong Hao

24 papers receiving 596 citations

Peers

Yarong Hao
Kamran Anwar United States
Michał W. Łuczak United States
Ke Su China
S. Janssens Belgium
Qi Cheng China
Kamran Anwar United States
Yarong Hao
Citations per year, relative to Yarong Hao Yarong Hao (= 1×) peers Kamran Anwar

Countries citing papers authored by Yarong Hao

Since Specialization
Citations

This map shows the geographic impact of Yarong Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yarong Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yarong Hao more than expected).

Fields of papers citing papers by Yarong Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yarong Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yarong Hao. The network helps show where Yarong Hao may publish in the future.

Co-authorship network of co-authors of Yarong Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Yarong Hao. A scholar is included among the top collaborators of Yarong Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yarong Hao. Yarong Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yuanyuan, Yarong Hao, Chunyan Sun, et al.. (2025). Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis. Cellular and Molecular Immunology. 22(11). 1414–1426. 1 indexed citations
2.
Yang, Ningxi, et al.. (2024). Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice. Experimental and Clinical Endocrinology & Diabetes. 132(8). 420–430. 3 indexed citations
3.
Lu, Yiting, Yarong Hao, Yuanyuan Luo, et al.. (2024). Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis. Journal of Gastroenterology. 60(3). 340–355.
4.
Hao, Yarong, et al.. (2024). Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation. Journal of Gastroenterology. 59(9). 788–797. 7 indexed citations
5.
Yang, Ningxi, et al.. (2024). Echinacoside Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Ferroptosis via Nrf2/HMOX1 Pathway. Biomedicines. 12(12). 2728–2728. 2 indexed citations
6.
Wang, Chenyu, et al.. (2023). Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism. Mediators of Inflammation. 2023. 1–13. 14 indexed citations
7.
Wang, Zhen, et al.. (2023). Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis. Molecular and Cellular Biochemistry. 478(9). 2111–2123. 2 indexed citations
8.
Wang, Chenyu, et al.. (2022). Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway. Journal of Orthopaedic Surgery and Research. 17(1). 406–406. 21 indexed citations
9.
Zhang, Xiang & Yarong Hao. (2020). <p>Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic <em>Db/Db</em> Mice</p>. Drug Design Development and Therapy. Volume 14. 5575–5587. 17 indexed citations
10.
Zhang, Xiang, et al.. (2019). A review of fibroblast growth factor 21 in diabetic cardiomyopathy. Heart Failure Reviews. 24(6). 1005–1017. 33 indexed citations
11.
Hao, Yarong, et al.. (2018). Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. Biochemical and Biophysical Research Communications. 503(2). 564–571. 15 indexed citations
12.
Zhang, Xue, Wan‐Qiang Lv, Bo Qiu, et al.. (2018). Assessing causal estimates of the association of obesity-related traits with coronary artery disease using a Mendelian randomization approach. Scientific Reports. 8(1). 7146–7146. 13 indexed citations
13.
Lǚ, Jianbo, Kai Xu, Jinmei Yang, Yarong Hao, & Fang Cheng. (2017). Nano iron oxide impregnated in chitosan bead as a highly efficient sorbent for Cr(VI) removal from water. Carbohydrate Polymers. 173. 28–36. 93 indexed citations
14.
Hao, Yarong, et al.. (2017). Effect of echinacoside on kidney fibrosis by inhibition of TGF-&beta;1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. Drug Design Development and Therapy. Volume 11. 2813–2826. 61 indexed citations
15.
Qin, Jian, Qianshan Ding, Xiang Ji, et al.. (2014). The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells. Molecular and Cellular Biochemistry. 395(1-2). 99–107. 38 indexed citations
16.
Liu, Min, Jian Qin, Yarong Hao, et al.. (2013). Astragalus Polysaccharide Suppresses Skeletal Muscle Myostatin Expression in Diabetes: Involvement of ROS-ERK and NF-κB Pathways. Oxidative Medicine and Cellular Longevity. 2013. 1–10. 63 indexed citations
17.
Zhu, Lihua, Yarong Hao, Hongjing Guan, et al.. (2012). Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice. Molecular and Cellular Biochemistry. 373(1-2). 53–62. 16 indexed citations
18.
Wu, C., et al.. (2012). 815 CHARACTERISTICS OF T CELL SUBSETS AND PROGRAMMED DEATH 1 EXPRESSION ON T CELLS IN HBV-RELATED HEPATOCELLULAR CARCINOMA (HCC). Journal of Hepatology. 56. S318–S319. 1 indexed citations
19.
Hao, Yarong, et al.. (2011). The effect of vascular endothelial growth factor on aggrecan and type II collagen expression in rat articular chondrocytes. Rheumatology International. 32(11). 3359–3364. 23 indexed citations
20.
Hao, Yarong, et al.. (2006). Effects of Pioglitazone on Elderly Patients with Type 2 Diabetes Mellitus. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026